◆ 会议时间：2024年3月21日至23日
◆ 会议地点：西班牙 巴塞罗那

◆ 会议简介：

2024年第9届国际头颈部肿瘤创新方法联合大会(ICHNO)将于2024年3月21日至23日在西班牙巴塞罗那举行，会议由欧洲放射治疗与肿瘤学学会(ESTRO)、欧洲头颈学会(EHNS)和欧洲肿瘤内科学会(ESMO)联合主办，每两年举办一次，ICHNO是宣推动多学科头颈部肿瘤学发展的国际盛会。ICHNO将成为一个独特的传播头颈部肿瘤学领域最相关和最前沿的科学与创新的平台。领域国际医学会议网翻译整理，未经本站许可禁止复制摘录转载本站任何内容(lingyuint.com)。

ICHNO 2024
The 9th Joint International Congress on Innovative Approaches in Head and Neck Oncology (9th ICHNO)

Date: 21-23 March 2024
Vneue: Barcelona, Spain

重要日期：

Abstract submission

The submission deadline is on 11 October 2023 (23h59 CET). 

点此提交摘要>>>Submit Abstract>>>

REGULATIONS  

The submitting author of an abstract: 

• Accepts responsibility for the accuracy of the abstract and ascertains that all authors are aware of the content before submission.
• Accepts to be the contact person for all correspondence related to the abstract and to inform the co-authors about its status.
• Confirms that all authors contributing to the abstract are properly included in the author list.
• Accepts to disclose any financial interest in products or processes described in the abstract. This includes stock ownership, membership on any advisory boards, commercially sponsored research or any other substantial relationships.  
• Certifies that, if the abstract is selected, the information reported is for the exclusive presentation in the scientific programme and will not be presented at any commercially-sponsored satellite symposia during the congress.  
• Abstracts are embargoed until 1 month prior to the congress at which point the abstract book is published on the website and abstracts are included in the online searchable programme. Should you wish for an abstract to be embargoed until the congress, please email abstracts@estro.org by 28 February 2024. 
• Abstracts must be submitted and presented in English. The Scientific Programme Committee reserves the right to reject an abstract written in poor English. 
• Accepts that no edits to the abstract or author list are possible after the submission deadline of 11 October 2023.
• Accepts to check the abstract overview provided in the submission confirmation email and ensure all abstract details are correct.

TOPICS & KEYWORDS

• Please note that abstracts are reviewed by experts in the topic chosen.
• Submitting to the wrong topic may result in your abstract receiving a lower score.

TOPICS

• Choose the topic category that refers to the main subject of the abstract. The Scientific Programme Committee reserves the right to re-categorise the abstract.

• Epidemiology and prevention
• Imaging, radiomics and artificial intelligence
• HPV or EBV related cancers
• Innovative treatments
• Minimal invasive and reconstructive surgery
• Multidisciplinary management
• Biology and molecular targeting
• Immuno-oncology
• Supportive care, rehabilitation
• Salivary gland, skull base, skin and thyroid cancers
• Management of elderly or frail patients
•  Quality of life and outcomes

KEYWORDS

• Authors are required to write 1 to 3 keywords (different from the topic) that best describe their work. 

PRESENTATION PREFERENCE

• Authors should indicate their presentation preference (“live presentation” or “digital poster”).
• Please note that opting for “digital poster” will mean that your abstract will not be considered for presentation as a proffered paper, mini-oral or poster discussion by the Scientific Programme Committee.
• Selecting “live presentation” does not guarantee selection for an oral presentation and the abstract may still be assigned as a digital poster.
• Please choose the “digital poster” option only if you are not able to deliver a live presentation at the congress (due to language limitations or travel restrictions for example).  

ABSTRACT

TITLE

• Abstract titles should be brief and reflect the content of the abstract
• The title (maximum 100 characters) is important since it focuses attention (it is the “showcase” for the presentation).
• Do not use capital letters in the title except for words that are always capitalised and do not use non-standard abbreviations.
• Prospective clinical trials should be identified as such in the title of the abstract (include The National Clinical Trial number when applicable) 

ABSTRACT BODY

Abstracts should be structured in such a way as to include:

1. Purpose/Objective
2. Material/Methods
3. Results
4. Conclusion

ABSTRACT CONTENT

• Abstracts on research obviously not yet performed and results not yet obtained will be rejected.
• Case studies will not be considered (unless if first-in-human) .
• Systematic reviews are accepted but literature reviews are not.
• Papers already presented at another meeting will not be considered, unless the previous audience is distinct from the ESTRO 2023 congress audience (e.g. national meetings).  
• Abstracts should include new information and not solely include materials already published. 
• If very similar abstracts are submitted by the same authors, the Scientific Programme Committee reserves the right to select only one of the abstracts and reject any others. 

ONLINE ABSTRACT SUBMISSION PROCEDURE

• The online abstract submission system will not accept abstracts that exceed 3,000 characters (body of the abstract, including spaces).  
• The use of standard abbreviations is desirable. A special or unusual abbreviation must be placed (in round brackets) after the first appearance of the word for which it stands.  
• Tables and images may be included in an abstract but must be limited to two uploads (tables or images) in JPG or PNG formats. These uploads are not included in the character count. The maximum pixel size of an image is 600(w) x 800 (h) pixel. Larger images will not be properly visible in the abstract. Please ensure the content of the image is readable at this size. Abstracts containing multiple tables or figures with one image upload will be penalised during the review process.
• Authors may include one data table using the insert table icon (we advise not to copy-paste a table into the body of the abstract). The characters in a data table are included in the character count.  
• Equations can be inserted in the text as images.  

ABSTRACT EDITING

• Abstracts can be edited until the submission deadline of 11 October 2023.
• Any changes to abstract are not accepted after this date. 
• Please ensure all authors are included in the list and appear correctly in the abstract overview.
• After submission you will receive a confirmation email containing a link to the abstract overview. Please click on this link and check the abstract is complete and has no errors or omissions.

ABSTRACT SELECTION PROCESS  

• Abstracts submitted for presentation will be peer-reviewed by an international panel of experts in the field of the subject.  
• Abstract review criteria are based on clarity, supporting data, scientific rigour, potential significance, interest in the topic chosen and innovation or usefulness.
• Abstract scores will guide the Scientific Programme Committee in selecting the abstracts for the different presentation formats.
• Notifications of abstract selection will be sent early December 2023.
• Please note that acceptance of an abstract does not entitle the authors to a complimentary registration. Presenting authors should register for the congress by the early registration deadline.

PRESENTATION FORMATS

• Abstracts selected for Proffered Paper comprise a PowerPoint presentation of 7 minutes with 3 minutes for discussion.
• Abstracts selected for Digital Poster are included in the digital poster gallery where they are grouped by topic and are displayed onsite and in the online platform.

ABSTRACT WITHDRAWAL

• Submitted abstracts can be withdrawn until 8 November 2023.
• To withdraw your abstract, you should send an email to abstracts@estro.org).
• After this date, withdrawal of abstracts is no longer possible.
• If the presenting author cannot attend the congress, they should nominate a co-author and inform the ESTRO office as soon as possible. 

Welcome

The joint International Congress on Innovative Approaches in Head and Neck Oncology (9th ICHNO) is taking place in Barcelona, Spain from 21 to 23 March 2024.

The European SocieTy for Radiotherapy and Oncology (ESTRO), the European Head and Neck Society (EHNS) and the European Society of Medical Oncology (ESMO) have the pleasure to invite you to participate in this congress.

This biennial congress promises to provide a unique platform for the dissemination of the most relevant and cutting-edge science and innovation in the field of head and neck oncology. The format of the meeting will include prestigious invited ‘state of the art lectures’ and presentations on the latest developments in the field of head and neck oncology. There will be also a special focus on presentations of new data from practice changing randomised trials. Ample time will be given for discussions to allow in-depth interaction among the various disciplines and the participants.

The multidisciplinary of the sessions will foster and promote interaction between the various specialties attending.

We hope to see you all in Barcelona for this unmissable congress!

Chairpersons of the 9th ICHNO congress

注册费：

◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。